Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcome | Charles Explorer

Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcome

Publikace

Abstrakt

Weekly trastuzumab

Osoby